The following amendments have been made to the ‘Glycotest Completes $10m Series A Round with Fosun’ announcement (RNS Number: 6823E) released on 22 October 2018 at 07:00AM: The following sentence: Upon satisfaction of the contingent ODI approval, NetScientific’s controlling interest will be 50.4% of Glycotest Inc. calculated on a fully-diluted basis following the closing of the Series A Financing. Has been …
NetScientific plc
Level 39,
One Canada Square,
London, E14 5AB
Tel: +44 20 3514 1800
www.netscientific.net
info@netscientific.net
copyright
October 2018 - NetScientific